BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19431954)

  • 21. Fatal neonatal renal failure due to maternal enalapril ingestion.
    Murki S; Kumar P; Dutta S; Narang A
    J Matern Fetal Neonatal Med; 2005 Mar; 17(3):235-7. PubMed ID: 16147831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal exposure to lisinopril: neonatal manifestations and management.
    Bhatt-Mehta V; Deluga KS
    Pharmacotherapy; 1993; 13(5):515-8. PubMed ID: 8247923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
    Partosch F; Stahlmann R
    Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
    [No Abstract]   [Full Text] [Related]  

  • 24. [Are the theoretical drawbacks of beta-blocker treatment in pregnancy being confirmed? A review of the literature].
    Tcherdakoff P; Goupil-Colliard M
    J Pharmacol; 1983; 14 Suppl 2():143-50. PubMed ID: 6138464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs in pregnancy. Antihypertensives.
    Magee LA
    Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):827-45. PubMed ID: 11800527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute renal failure and hypertension].
    Bellido D; Sánchez de la Nieta MD; Vozmediano C; Oteros R; Zarca MA; Nieto J; Rivera F
    Nefrologia; 2005; 25(5):563-7. PubMed ID: 16392308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
    Sakairi A; Ishida J; Honjo K; Inaba S; Nakamura S; Sugiyama F; Yagami K; Fukamizu A
    Hypertens Res; 2008 Dec; 31(12):2165-75. PubMed ID: 19139606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II receptor blockers in pregnancy: a report of five cases.
    Gersak K; Cvijic M; Cerar LK
    Reprod Toxicol; 2009 Jul; 28(1):109-12. PubMed ID: 19491003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibitor fetopathy.
    Hegde AU; Parekji S; Ali US; Mehta KP
    Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of hypertension in pregnant women with beta-blockers. 60 cases (author's transl)].
    Dubois D; Petitcolas J; Temperville B; Klepper A
    Nouv Presse Med; 1980 Oct; 9(38):2807-10. PubMed ID: 6108548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.
    Marchetto L; Sordino D; De Bernardo G; Trevisanuto D
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26139648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it safe to fetus?
    Yip SK; Leung TN; Fung HY
    Acta Obstet Gynecol Scand; 1998 May; 77(5):570-1. PubMed ID: 9654182
    [No Abstract]   [Full Text] [Related]  

  • 33. Five cases of sprue-like enteropathy in patients treated by olmesartan.
    Théophile H; David XR; Miremont-Salamé G; Haramburu F
    Dig Liver Dis; 2014 May; 46(5):465-9. PubMed ID: 24472297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Non-steroidal anti-inflammatory agents and pregnancy. A study of renal and digestive toxicity of niflumic acid in the perinatal period].
    Alessandri JL; Abossolo T; Reynaud I; Montbrun A; Sommer JC; Tilmont P
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(7):813-8. PubMed ID: 7822716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sprue-like enteropathy due to olmesartan: a case report].
    Agudo Fernández S
    Gastroenterol Hepatol; 2015 Feb; 38(2):108-9. PubMed ID: 24958550
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome.
    Haaland K
    J Headache Pain; 2010 Apr; 11(2):167-9. PubMed ID: 20063032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olmesartan-induced enteropathy.
    Heerasing N; Hair C; Wallace S
    Intern Med J; 2015 Jan; 45(1):117-8. PubMed ID: 25582943
    [No Abstract]   [Full Text] [Related]  

  • 38. [Severe enteropathy with villous atrophy olmesartan medoxomil-associated].
    Nunge D; Eoche M; Fumery M; Nguyen-Khac E; Gras V; Andréjak M
    Therapie; 2013; 68(6):419-21. PubMed ID: 24246126
    [No Abstract]   [Full Text] [Related]  

  • 39. Teratogenicity with angiotensin II receptor antagonists in pregnancy.
    Boix E; Zapater P; Picó A; Moreno O
    J Endocrinol Invest; 2005 Dec; 28(11):1029-31. PubMed ID: 16483184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of 6-years' use of beta blocking agents in the treatment of arterial hypertension in pregnancy (143 case reports recorded between May 1976 and December 1982)].
    Monnier JC; Valat AS; Lanciaux B; Dognin C
    LARC Med; 1984 Feb; 4(2):61-6. PubMed ID: 6144020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.